Flu vaccine for the upcoming season has begun shipping from five manufacturers. All three strains of virus have been changed this season, following mismatches in last season’s vaccine.

• Plenty of Downsides, Little Upside to Adding Rifampin for Staph Endocarditis
• Empirical Fluconazole Not Beneficial in Critically Ill Adults at Risk for Candida
• Two Nucleic Acid Amplification Tests Detect Pharyngeal and Rectal Gonorrhea, Chlamydia
• Darunavir as First-line Therapy?
• Risk-Factor Screening Does Not Predict HPV Infection

• Valganciclovir to Prevent Kaposi Sarcoma?
• Genetics of Smallpox Vaccine Adverse Events
• Iron Deficiency Protects Pregnant Women against Malaria
• Control of an Institutional Outbreak of Influenza
• Catheter Lock Solutions for Hemodialysis
• MRSA Infection Risk in Long-term Carriers 

Is IV clindamycin effective at dosages lower than the recommended 900 mg every 8 hours?

• Ziagen (abacavir sulfate) hypersensitivity reactions

IDSA and SHEA were successful this summer in making the case that Medicare should take a cautious approach in implementing a new policy to limit payment for hospital-acquired conditions.

Before you head out to Washington, DC for the 48^th ICAAC/IDSA 46^th Annual Meeting, check out the sessions and plan your schedule with the Online Program Planner.

Congress this month passed legislation requiring drug manufacturers to report to the Food and Drug Administration (FDA) the quantities of antibiotics sold for use in food animals.

Applications are now being accepted for physicians and scientists to participate in a review panel that will evaluate the literature and other information on Lyme disease in order to make a recommendation to IDSA on the need for a revision or update of the Society's 2006 Lyme disease guidelines.

Election ballots due September 15